ASS1 and neoplasm: Indeed, the ASS1 mRNA levels appears to be significantly upregulated in ~ 9% of primary HNSCC and a strong negative correlation between high tumor ASS1 levels and clinical outcome (relapse-free and overall survival) is observed in the HNSCC patient cohort of The Cancer Genome Atlas (TCGA) dataset.